A bolus/infusion paradigm for the novel NMDA receptor SPET tracer [123i]CNS 1261
- 29 February 2004
- journal article
- clinical trial
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 31 (2) , 155-164
- https://doi.org/10.1016/j.nucmedbio.2003.08.008
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Kinetic modelling of [123I]CNS 1261—a potential SPET tracer for the NMDA receptorNuclear Medicine and Biology, 2003
- PET studies of 18 F-memantine in healthy volunteersNuclear Medicine and Biology, 2002
- Imaging the glutamatergic system in vivo – relevance to schizophreniaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2000
- Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers*Clinical Pharmacology & Therapeutics, 1995
- Memories of NMDA receptors and LTPTrends in Neurosciences, 1995
- Spatial registration and normalization of imagesHuman Brain Mapping, 1995
- Comparison of Bolus and Infusion Methods for Receptor Quantitation: Application to [18F]Cyclofoxy and Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1993
- Excitatory amino acid receptors and synaptic plasticityTrends in Pharmacological Sciences, 1990
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- A Method for Attenuation Correction in Radionuclide Computed TomographyIEEE Transactions on Nuclear Science, 1978